Ri Xiang Kong
Direttore Tecnico/Scientifico/R&S presso Beijing Biostar Pharmaceuticals Co. Ltd.
Posizioni attive di Ri Xiang Kong
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
 Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | 01/03/2021 | - |
| Direttore Tecnico/Scientifico/R&S | 01/12/2018 | - |
Storia della carriera di Ri Xiang Kong
Formazione di Ri Xiang Kong
| Tianjin University of Science & Technology | Graduate Degree |
Statistiche
Distribuzione geografica
| Cina | 3 |
Posizioni
| Graduate Degree | 1 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Consumer Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Ri Xiang Kong
- Esperienza
